SkinCancer360

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy
Featured image for “Checkpoint Therapeutics Receives Approval for PD-L1 Therapy”

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy

December 16, 2024
The approval of cosibelimab-ipdl provides an option for patients with cutaneous squamous cell carcinoma December 13, 2024 (Sacramento, California) The…
Featured image for “AIM at Melanoma Announces the Launch of AIM at Skin Cancer”

AIM at Melanoma Announces the Launch of AIM at Skin Cancer

January 22, 2024
New Website Dedicated to Providing Individuals with Vital Knowledge and Tools to Protect Their Skin and Lead Healthy Lives January…
[wpb_childpages]

Recent Posts

Featured image for “My Skin Cancer Was Removed. Why Do I Still Need Follow-Up Care?”
Jun. 29, 2026

My Skin Cancer Was Removed. Why Do I Still Need Follow-Up Care?

Featured image for “Exploring Strategies for Home Skin Checks Tailored for Someone with Limited Mobility”
Jun. 23, 2026

Exploring Strategies for Home Skin Checks Tailored for Someone with Limited Mobility

Featured image for “The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public”
Jun. 10, 2026

The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public

Featured image for “Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges”
Jun. 03, 2026

Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges

Featured image for “What Patients Should Know About the Rising Rates of Skin Cancer”
May. 22, 2026

What Patients Should Know About the Rising Rates of Skin Cancer

Post Categories